Researchers present sensor prototype that can rapidly, precisely, and cost-effectively measure molecular signals for cancer
The CRISPR/Cas technology can do more than alter genes. A research team at the University of Freiburg is using what are known as gene scissors – which scientists can use to edit genetic material – in order to better diagnose diseases such as cancer. In a study, the researchers introduce a microfluidic chip which recognizes small fragments of RNA, indicating a specific type of cancer more rapidly and precisely than the techniques available up to now. The results are recently published in the scientific journal “Advanced Materials.” They also tested the CRISPR biosensor on blood samples taken from four children who had been diagnosed with brain tumors. “Our electrochemical biosensor is five to ten times more sensitive than other applications which use CRISPR/Cas for RNA analysis,” explains Freiburg microsystems engineer Dr. Can Dincer. He is leading the research team together with biologist Prof. Dr. Wilfried Weber, of the University of Freiburg. “We’re doing pioneering work in Germany and Europe for this new application of gene scissors,” Dincer emphasizes.
Short molecules known as microRNA (miRNA) are coded in the genome, but unlike other RNA sequences, they are not translated into proteins. In some diseases, such as cancer or the neurodegenerative disease, Alzheimer’s, increased levels of miRNA can be detected in the blood. Doctors are already using miRNAs as a biomarker for certain types of cancer. Only the detection of a multitude of such signaling molecules allows an appropriate diagnosis. The researchers are now working on a version of the biosensor that recognizes up to eight different RNA markers simultaneously.
The CRISPR biosensor works as follows: A drop of serum is mixed with reaction solution and dropped onto the sensor. If it contains the target RNA, this molecule binds with a protein complex in the solution and activates the gene scissors – in a way similar to a key opening a door lock. Thus activated, the CRISPR protein cuts off, or cleaves, the reporter RNAs that are attached to signaling molecules, generating an electrical current. The cleavage results in a reduction of the current signals which can be measured electrochemically and indicates if the miRNA that is being sought is present in the sample. “What’s special about our system is that it works without the replication of miRNA, because in that case, specialized devices and chemicals would be required. That makes our system low-cost and considerably faster than other techniques or methods,” explains Dincer. He is working on new sensor technologies at the Freiburg Center for Interactive Materials and Bioinspired Technologies (FIT) and together with Prof. Dr. Gerald Urban at the Department of Microsystems Engineering (IMTEK).
Weber, a professor of synthetic biology at the cluster of excellence CIBSS – the Centre for Integrative Biological Signalling Studies of the University of Freiburg – emphasizes how important the interdisciplinary environment at CIBSS is for such a development: “The biologists at Freiburg work together on these technologies with their colleagues from the engineering and materials sciences. That opens new, exciting routes to solutions.” The researchers are aiming to further develop the system in about five to ten years to become the first rapid test for diseases with established microRNA markers that can be used right at the doctor’s office. “The laboratory equipment must nevertheless become easier to handle,” says Weber.
Learn more: Using Gene Scissors to Detect Diseases
The Latest Google Headlines on:
Disease detection
[google_news title=”” keyword=”disease detection” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Disease detection
- Health Ministry Launches Early Detection and Treatment Campaign Against Liver Canceron April 28, 2024 at 9:07 am
AstraZeneca Egypt has announced its collaboration with the Ministry of Health and Population to inaugurate a campaign focused on the early detection and treatment of hepatocellular carcinoma (HCC), ...
- AstraZeneca Egypt and MoHP launch early detection and treatment campaign against liver canceron April 27, 2024 at 5:00 pm
Furthermore, it introduces cutting-edge international methodologies for early diagnosis and detection of liver diseases, particularly liver cancer, aiming to enhance patient response rates to ...
- Chronic wasting disease detected in Edwards County deer breeding facilityon April 25, 2024 at 11:24 am
The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.
- Owlstone Medical secures $6.5 million to support development of breath-based diagnostics for infectious diseaseon April 25, 2024 at 8:52 am
Owlstone Medical (“Owlstone”), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced it has secured funding from the Bill & Melinda ...
- Fatal ‘zombie deer’ disease found in Harpers Ferry National Historical Parkon April 24, 2024 at 12:20 pm
Two white-tailed deer inside Harpers Ferry National Historical Park in West Virginia have tested positive for the fatal Chronic Wasting Disease.
- Company developing early cancer-detection tests to cut 20% of workforceon April 24, 2024 at 7:35 am
Early cancer-detection test maker that raised $254 million earlier this year now says it will cut more than 100 jobs — about 20% of its workforce — as it restructures ...
- 2024 Report | European Biopsy Devices Market to Reach US$ 1,074.0 Million by 2032: Enhanced Focus on Early Disease Detection Fuels Growthon April 24, 2024 at 6:41 am
It is projected to grow at a CAGR of 5.99% from 2024 to 2032. The analyst forecasts it to reach US$ 1,074.0 Million by 2032. The increasing emphasi ...
- Researchers aim to use AI for early screening and prognosis of Dry Eye Diseaseon April 23, 2024 at 1:19 pm
Dry Eye Disease (DED) is one of the more common eye diseases, affecting up to 30% of the world's population. This disease can affect many different types of people and can wind up being a great ...
- Artificial intelligence to be used for the detection of common eye diseaseon April 23, 2024 at 6:14 am
Here is where the combined efforts of ophthalmic disease detection and the world of computer scientists and engineers can help. “By addressing challenges, imparting insights, and delineating future ...
- Leveling the field: MSU researcher develops new, affordable detection and monitoring methods for cardiovascular diseaseon April 22, 2024 at 9:25 am
A Mississippi State University researcher is developing new, more affordable methods for early detection and monitoring of cardiovascular disease, the leading cause of death in the U.S.
The Latest Google Headlines on:
CRISPR biosensor
[google_news title=”” keyword=”CRISPR biosensor” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
CRISPR biosensor
- Tau Toggling Peptides: One Seeds Fibrils; the Other Dismantles Themon April 19, 2024 at 4:36 pm
Destructive Relief. In the proposed strain relief mechanism, left-twisted tau fibrils bind D-peptides, which initially adopt tau’s left-handed twist to form paired fibrils. Structurally strained, ...